EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/1540963
pq Statistically significant difference between years (all above charts) CATARACT 2024 2025 Averages Cataract surgery patients with ocular comorbidities 36% 22% q Favorite nuclear fragmentation technique Divide and conquer 36% 41% p Horizontal chop 25% 30% p Vertical chop 17% 14% Pre-chop 5% 5% miLOOP (Zeiss) 0% 1% Ancillary devices/instruments/implants used during cataract surgery Trypan blue 81% 78% Capsule tension ring 68% 70% Non-hook pupillary expansion device 52% 47% q OVD soft shell technique 47% 39% Pupil hook 43% 41% Capsule retractor 35% 35% Sutures to fixate an IOL 28% 31% Sutures to repair an iris defect 27% 28% Capsule tension segment 19% 20% miLOOP (Zeiss) 14% 13% Artificial iris device 9% 10% Zepto (Centricity Vision) 3% 3% CATARACT 2024 2025 Comfort level in performing anterior vitrectomy Comfortable with limbal approach only 56% 52% Comfortable with pars plana approach only 6% 6% Comfortable with both 27% 22% q Comfortable with either 8% 7% Do not perform anterior vitrectomy 3% 13% p FLACS Currently perform 42% 35% q Plan to in the next 12 months 11% 11% No and have no plans 47% 54% p ASTIGMATISM MANAGEMENT 2024 2025 Target "sweet spot" for residual refractive astigmatism 0.5 D or greater with-the-rule 16% 14% 0.3 D with-the-rule 39% 33% q 0 D 21% 20% 0.3 D against-the-rule 6% 4% 0.5 D or greater against-the-rule 4% 3% I do not have a "sweet spot" 14% 26% p Reasons for not implanting toric IOLs Toric IOLs are not available to me 20% 16% Not enough surgical training to integrate into my practice 19% 15% Cost to the patient 14% 14% Do not implant eyes with significant irregular astigmatism 3% 13% p Do not meet expectations for visual outcomes 3% 6% Additional time needed to manage these patients 3% 3% Difficulty in managing residual postop refractive error 1% 3% Available toric powers not low or high enough 5% 3% Average degrees of postop rotational error acceptable 10.0 8.6 PRESBYOPIA CORRECTION 2024 2025 Reasons for not performing presbyopia-correcting procedures Lack of accessibility to laser vision correction to correct residual error 11% 10% I do not present option; I don't think patients will want to pay out of pocket 10% 9% Concern over quality vision 16% 8% q I'd like to present option, but my patients cannot afford the additional cost 10% 7% Concern over inadequate unaided distance 6% 7% Prevalence over ocular co-morbidities 11% 6% Concern over inadequate near vision 6% 4% Concern over inadequate unaided intermediate vision 3% 1% Other 62% 67% p Spherical deviation from intended target considered visually significant ≥0.25 D and ≤0.50 D 38% 30% q >0.50 D and ≤0.75 D 47% 50% >0.75 D and ≤1.0 D 11% 16% p >1.0 D and ≤1.25 D 3% 3% >1.25 D and ≤1.5 D 1% 1% % who would like to increase presbyopia-correcting implants Yes 76% 62% q No 24% 38% p Shifts from 2024 – Cataract, Astigmatism Management, and Presbyopia Correction CORNEA 2023 2025 Guidelines used when assessing and treating ocular surface The ASCRS Algorithm 20% 21% DEWS I 7% 5% DEWS II 26% 21% q The CEDARS Algorithm 3% 3% Other 8% 16% p I don't use any of these 49% 44% q Barriers to performing corneal collagen crosslinking Staff or practice logistics 29% 27% Lack of patient population or referrals 22% 19% Inadequate or uncertain reimbursement 18% 13% q Perceived lack of efficacy 4% 7% Labeling or regulatory approval status 6% 6% Other 37% 41% Conditions treating corneal collagen crosslinking Keratoconus 97% 91% q Post-refractive ectasia 67% 61% q Post-RK 13% 13% Combined refractive procedure to proactively enhance stability 16% 12% q Other 1% 4% CORNEA 2023 2025 Preference for posterior cornea transplant patient DMEK 34% 35% DSEK 17% 13% q No opinion 49% 52% Premium IOL considered appropriate Small aperture IOL 26% 19% q Toric IOL 16% 12% EDOF IOL 12% 12% Multifocal IOL 4% 6% Pseudo accommodating IOL 1% 1% I would not implant a premium IOL in an irregular cornea 41% 50% p Shifts from 2023 – Cornea

